Annual D&A
$340.70 K
+$1900.00+0.56%
December 1, 2023
Summary
- As of February 7, 2025, ADXN annual depreciation & amortization is $340.70 thousand, with the most recent change of +$1900.00 (+0.56%) on December 1, 2023.
- During the last 3 years, ADXN annual D&A has fallen by -$63.30 thousand (-15.67%).
- ADXN annual D&A is now -89.72% below its all-time high of $3.31 million, reached on December 31, 2011.
Performance
ADXN Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$71.20 K
-$50.40 K-41.45%
September 1, 2024
Summary
- As of February 7, 2025, ADXN quarterly depreciation & amortization is $71.20 thousand, with the most recent change of -$50.40 thousand (-41.45%) on September 1, 2024.
- Over the past year, ADXN quarterly D&A has dropped by -$17.10 thousand (-19.37%).
- ADXN quarterly D&A is now -41.45% below its all-time high of $121.60 thousand, reached on June 1, 2024.
Performance
ADXN Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$357.50 K
-$17.10 K-4.56%
September 1, 2024
Summary
- As of February 7, 2025, ADXN TTM depreciation & amortization is $357.50 thousand, with the most recent change of -$17.10 thousand (-4.56%) on September 1, 2024.
- Over the past year, ADXN TTM D&A has increased by +$18.40 thousand (+5.43%).
- ADXN TTM D&A is now -13.33% below its all-time high of $412.50 thousand, reached on September 30, 2020.
Performance
ADXN TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
ADXN Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +0.6% | -19.4% | +5.4% |
| 3 y3 years | -15.7% | -22.7% | -6.0% |
| 5 y5 years | +10000.0% | -15.6% | +6.4% |
ADXN Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -10.4% | +0.6% | -41.5% | at low | -6.0% | +9.5% |
| 5 y | 5-year | -15.7% | +1.4% | -41.5% | at low | -13.3% | +9.5% |
| alltime | all time | -89.7% | >+9999.0% | -41.5% | at low | -13.3% | +366.1% |
Addex Therapeutics Ltd Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $71.20 K(-41.4%) | $357.50 K(-4.6%) |
| Jun 2024 | - | $121.60 K(+51.1%) | $374.60 K(+10.4%) |
| Mar 2024 | - | $80.50 K(-4.4%) | $339.40 K(-0.4%) |
| Dec 2023 | $340.70 K(+0.6%) | $84.20 K(-4.6%) | $340.70 K(+0.5%) |
| Sep 2023 | - | $88.30 K(+2.2%) | $339.10 K(+2.5%) |
| Jun 2023 | - | $86.40 K(+5.6%) | $330.70 K(+1.3%) |
| Mar 2023 | - | $81.80 K(-1.0%) | $326.60 K(-3.6%) |
| Dec 2022 | $338.80 K(-10.9%) | $82.60 K(+3.4%) | $338.80 K(-2.7%) |
| Sep 2022 | - | $79.90 K(-2.9%) | $348.30 K(-3.9%) |
| Jun 2022 | - | $82.30 K(-12.4%) | $362.40 K(-3.7%) |
| Mar 2022 | - | $94.00 K(+2.1%) | $376.30 K(-1.1%) |
| Dec 2021 | $380.30 K(-5.9%) | $92.10 K(-2.0%) | $380.30 K(+1.4%) |
| Sep 2021 | - | $94.00 K(-2.3%) | $375.00 K(-5.8%) |
| Jun 2021 | - | $96.20 K(-1.8%) | $398.30 K(-1.1%) |
| Mar 2021 | - | $98.00 K(+12.9%) | $402.60 K(-0.3%) |
| Dec 2020 | $404.00 K | $86.80 K(-26.0%) | $404.00 K(-2.1%) |
| Sep 2020 | - | $117.30 K(+16.7%) | $412.50 K(+8.7%) |
| Jun 2020 | - | $100.50 K(+1.1%) | $379.60 K(+5.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $99.40 K(+4.3%) | $358.70 K(+6.8%) |
| Dec 2019 | $336.00 K(>+9900.0%) | $95.30 K(+12.9%) | $336.00 K(+39.6%) |
| Sep 2019 | - | $84.40 K(+6.0%) | $240.70 K(+54.0%) |
| Jun 2019 | - | $79.60 K(+3.8%) | $156.30 K(+103.8%) |
| Mar 2019 | - | $76.70 K | $76.70 K |
| Dec 2018 | $3000.00(-80.6%) | - | - |
| Dec 2017 | $15.50 K(-40.8%) | - | - |
| Dec 2016 | $26.20 K(-2.6%) | - | - |
| Dec 2015 | $26.90 K(-77.7%) | - | - |
| Dec 2014 | $120.50 K(-83.1%) | - | - |
| Dec 2013 | $715.00 K(-68.1%) | - | - |
| Dec 2012 | $2.24 M(-32.3%) | - | - |
| Dec 2011 | $3.31 M(+18.0%) | - | - |
| Dec 2010 | $2.81 M(+7.3%) | - | - |
| Dec 2009 | $2.62 M(+40.3%) | - | - |
| Dec 2008 | $1.87 M(+24.2%) | - | - |
| Dec 2007 | $1.50 M(-25.4%) | - | - |
| Dec 2006 | $2.01 M | - | - |
FAQ
- What is Addex Therapeutics Ltd annual depreciation & amortization?
- What is the all time high annual D&A for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd annual D&A year-on-year change?
- What is Addex Therapeutics Ltd quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd quarterly D&A year-on-year change?
- What is Addex Therapeutics Ltd TTM depreciation & amortization?
- What is the all time high TTM D&A for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd TTM D&A year-on-year change?
What is Addex Therapeutics Ltd annual depreciation & amortization?
The current annual D&A of ADXN is $340.70 K
What is the all time high annual D&A for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high annual depreciation & amortization is $3.31 M
What is Addex Therapeutics Ltd annual D&A year-on-year change?
Over the past year, ADXN annual depreciation & amortization has changed by +$1900.00 (+0.56%)
What is Addex Therapeutics Ltd quarterly depreciation & amortization?
The current quarterly D&A of ADXN is $71.20 K
What is the all time high quarterly D&A for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high quarterly depreciation & amortization is $121.60 K
What is Addex Therapeutics Ltd quarterly D&A year-on-year change?
Over the past year, ADXN quarterly depreciation & amortization has changed by -$17.10 K (-19.37%)
What is Addex Therapeutics Ltd TTM depreciation & amortization?
The current TTM D&A of ADXN is $357.50 K
What is the all time high TTM D&A for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high TTM depreciation & amortization is $412.50 K
What is Addex Therapeutics Ltd TTM D&A year-on-year change?
Over the past year, ADXN TTM depreciation & amortization has changed by +$18.40 K (+5.43%)